SCHEMBL20883271

SCHEMBL20883271

C=CC(=O)OCCCCOc1ccc(C(=O)Oc2ccc(C(=O)Oc3ccc(OC(=O)c4ccc(OCCCCOC(=O)C=C)cc4)c(C)c3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
LMNA P02545 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
THRB P10828 1/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PRSS1 P07477 1/20 0.41
ACR P10323 1/20 0.41
HTT P42858 2/20 0.41
TSHR P16473 2/20 0.40
HPGD P15428 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16425803 1.00 NPC1 (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL12794265 1.00 NPC1 (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL18803342 1.00 NPC1 (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL13944904 0.99 NPC1 (0.45) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL29809767 0.99 THRB (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL102915 0.99 THRB (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL23848138 0.98 THRB (0.47) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL816945 0.98 NPC1 (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL10061462 0.98 NPC1 (0.44) NPC1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL17301280 0.98 THRB (0.43) NPC1LMNACYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002679-A1 COMPOUND AND LIQUID CRYSTAL COMPOSITION FUJIFILM CORPORATION (JP) 2023-01-05 US disclosed
US-11522165-B2 Organic EL image display device FUJIFILM CORPORATION (JP) 2022-12-06 US disclosed
US-20220145181-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM FUJIFILM CORPORATION (JP) 2022-05-12 US disclosed
US-20210388269-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM FUJIFILM CORPORATION (JP) 2021-12-16 US disclosed
US-11193068-B2 Compound, liquid crystal composition, cured substance, optical anisotropic body, and reflection film FUJIFILM CORPORATION (JP) 2021-12-07 US disclosed
US-20210198230-A1 COMPOUND, COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM FUJIFILM CORPORATION (JP) 2021-07-01 US disclosed
US-20210189243-A1 COMPOUND, MIXTURE, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM FUJIFILM CORPORATION (JP) 2021-06-24 US disclosed
US-10998528-B2 Organic EL image display device FUJIFILM CORPORATION (JP) 2021-05-04 US disclosed
US-10854852-B2 Organic EL image display device FUJIFILM CORPORATION (JP) 2020-12-01 US disclosed
US-10692903-B2 Color filter for image sensor, image sensor, and method of manufacturing color filter for image sensor FUJIFILM CORPORATION (JP) 2020-06-23 US disclosed
US-20200071615-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, CURED SUBSTANCE, OPTICAL ANISOTROPIC BODY, AND REFLECTION FILM FUJIFILM CORPORATION (JP) 2020-03-05 US disclosed
US-20200075896-A1 ORGANIC EL IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2020-03-05 US disclosed
US-20190109161-A1 COLOR FILTER FOR IMAGE SENSOR, IMAGE SENSOR, AND METHOD OF MANUFACTURING COLOR FILTER FOR IMAGE SENSOR FUJIFILM CORPORATION (JP) 2019-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210388269-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM HTR1A, HTR5A, HTR1B NPC1 2393/4885LMNA 2446/4885CYP3A4 1994/4885
US-20210198230-A1 COMPOUND, COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM HTR1A, TPH1, HTR1B NPC1 2155/4885LMNA 2220/4885CYP3A4 1344/4885
US-20210189243-A1 COMPOUND, MIXTURE, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM HTR1A, HTR5A, HTR1B NPC1 3020/4885LMNA 1982/4885CYP3A4 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.